ECO Animal Health Group (LON:EAH) Rating Reiterated by Shore Capital

ECO Animal Health Group (LON:EAH)‘s stock had its “buy” rating reiterated by analysts at Shore Capital in a research report issued to clients and investors on Wednesday, MarketBeat Ratings reports.

ECO Animal Health Group Price Performance

ECO Animal Health Group stock traded up GBX 7.99 ($0.10) during mid-day trading on Wednesday, reaching GBX 120.49 ($1.51). 65,803 shares of the company’s stock traded hands, compared to its average volume of 141,106. The company has a quick ratio of 2.14, a current ratio of 3.16 and a debt-to-equity ratio of 4.57. ECO Animal Health Group has a 12-month low of GBX 82.67 ($1.04) and a 12-month high of GBX 124 ($1.56). The company has a market cap of £81.62 million, a price-to-earnings ratio of -5,990.00 and a beta of 0.07. The stock has a 50 day moving average of GBX 93.69 and a two-hundred day moving average of GBX 102.50.

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.